Preclinical Research Services for Brain Tumors

In vitro assays are evolving to be simpler, faster, non-invasive, and multi-informative. We offer a variety of in vitro assays for brain tumors using multiple methods at multiple levels and stages of disease development. We help you to conduct early screening of brain tumor patients, guide treatment protocols, treatment monitoring, and recurrence monitoring.

Animal models are the cornerstone of non-clinical evaluation work and are necessary before entering clinical trials. We are actively establishing a variety of animal models for brain tumor research to help you study the pathogenesis of brain tumors and treatment options.

Cell lines are more homogeneous and standardized than primary cultured cells and have an important role in brain tumor drug screening and toxicology studies. We can provide our clients with a variety of cell line development services and work on the development of brain tumor stem cells. This complete system can meet your multiple needs for brain tumor drug screening and disease research.

We offer genetically modified neural stem cell lines, which are genetically engineered to genetically modify neural stem cells to stably express specific exogenous genes, such as fluorescent proteins, neurotransmitter probes, calcium probes, and light-sensitive proteins.

We provide our customers with mice with a single genetic background and use rAAV vector to carry the target genome into the mice so that we can achieve the modeling of the corresponding disease animals and provide you with the relevant viral products. We can achieve large-scale production with high yield and stability.